Therapeutic VR sedation startup Oncomfort closes €10 million Collection A

Therapeutic VR sedation startup Oncomfort closes €10 million Series A

Oncomfort, a Belgian firm utilizing therapeutic digital actuality to alleviate ache and anxiousness, has raised €10 million ($11.eight million) in Collection A funding. Debiopharm and Crédit Mutuel Innovation led the spherical, which additionally noticed help from current shareholders and Belgium’s Walloon Area Regional Funding Firm.

WHAT IT DOES

Oncomfort was based in 2017, and launched its SedaKit for Digital Sedation product as an alternative choice to medicines in June of final yr.

HIMSS20 Digital

Be taught on-demand, earn credit score, discover merchandise and options. Get Began >>

Packaged inside a stand-alone briefcase containing the branded VR headset, the corporate says it could possibly ship therapies that both distract or deeply sedate sufferers throughout minor procedures, uncomfortable diagnostics or surgical procedures. These VR hypnotherapy modules can be found in 12 completely different languages, and are supposed for sufferers age six or extra.

The corporate’s strategy is supported by a handful of publications and posters, and based on the corporate greater than 60,000 have acquired the VR remedy since final yr’s launch.

WHAT IT’S FOR

Oncomfort CEO Mario Huyghe stated in a press release that the corporate will likely be trying to proceed growth of the platform, make new hires and speed up its push into new European and American markets.

MARKET SNAPSHOT

Medical purposes of VR vary from behavioral well being to neurorehabilitation, however ache remedies are by far probably the most established in literature. With a number of distributors reaching out to suppliers, healthcare VR advocates are actually trying to implementation and reimbursement as the following challenges for the digital remedy modality. After all, COVID-19 has additionally launched its fair proportion of hurdles – and alternatives – to therapeutic VR distributors.

ON THE RECORD

“We’re delighted to discover a scientifically validated digital instrument to help the general journey of sufferers, which incessantly consists of varied ranges of ache, anxiousness and concern,” Thierry Mauvernay, president of Debiopharm’s board of administrators, stated in a press release. “The truth that superior [VR] together with hypnotherapy and integrative therapeutic strategies can be utilized to successfully sedate sufferers is really spectacular and gives an fascinating choice for sufferers to seek out bodily and emotional aid,”



Supply hyperlink

Be the first to comment

Leave a Reply